Literature DB >> 22067831

The genetic toolbox for Leishmania parasites.

Sigrid C Roberts1.   

Abstract

Leishmania parasites cause a variety of devastating diseases in tropical areas around the world. Due to the lack of vaccines and limited availability of drugs, new therapeutic targets are urgently needed. A variety of genetic tools have been developed to investigate the complex biology of this parasite and its interactions with the host. One of the main techniques is the generation of knock-out parasites via targeted gene replacement, a process that takes advantage of the parasites ability to undergo homologous recombination. Studying the effect of gene deletions in vitro and in infectivity models in vivo allows understanding the function of a target gene and its potential as a therapeutic target. Other genetic manipulations available include episomal and chromosomal complementation and the generation of overproducer strains. However, there are also limitations, such as the lack of RNA interference machinery in most Leishmania species and limited options for inducible expression systems. The genomes of several Leishmania species have now been sequenced and will provide powerful resources in combination with the genetic tools that are available. The increasing knowledge of parasite biology and host parasite interactions derived from these studies will raise the number of potential therapeutic targets, which are sorely needed to combat leishmaniasis.

Entities:  

Mesh:

Year:  2011        PMID: 22067831      PMCID: PMC3242788          DOI: 10.4161/bbug.2.6.18205

Source DB:  PubMed          Journal:  Bioeng Bugs        ISSN: 1949-1018


  66 in total

Review 1.  Is lipophosphoglycan a virulence factor? A surprising diversity between Leishmania species.

Authors:  S J Turco; G F Späth; S M Beverley
Journal:  Trends Parasitol       Date:  2001-05

2.  New Mos1 mariner transposons suitable for the recovery of gene fusions in vivo and in vitro.

Authors:  S Goyard; L R Tosi; J Gouzova; J Majors; S M Beverley
Journal:  Gene       Date:  2001-12-12       Impact factor: 3.688

3.  A telomere-mediated chromosome fragmentation approach to assess mitotic stability and ploidy alterations of Leishmania chromosomes.

Authors:  S Tamar; B Papadopoulou
Journal:  J Biol Chem       Date:  2001-01-10       Impact factor: 5.157

4.  Generating knock-in parasites: integration of an ornithine decarboxylase transgene into its chromosomal locus in Leishmania donovani.

Authors:  Sigrid C Roberts; Chelsey Kline; Wei Liu; Buddy Ullman
Journal:  Exp Parasitol       Date:  2011-02-24       Impact factor: 2.011

5.  Artificial linear episome-based protein expression system for protozoon Leishmania tarentolae.

Authors:  Susanna Kushnir; Ion Cristian Cirstea; Lyudmyla Basiliya; Nataliya Lupilova; Reinhard Breitling; Kirill Alexandrov
Journal:  Mol Biochem Parasitol       Date:  2010-12-15       Impact factor: 1.759

Review 6.  Cell biology of Leishmania.

Authors:  E Handman
Journal:  Adv Parasitol       Date:  1999       Impact factor: 3.870

7.  Spermidine synthase is required for virulence of Leishmania donovani.

Authors:  Caslin Gilroy; Tamara Olenyik; Sigrid C Roberts; Buddy Ullman
Journal:  Infect Immun       Date:  2011-05-02       Impact factor: 3.441

8.  The Hus1 homologue of Leishmania major encodes a nuclear protein that participates in DNA damage response.

Authors:  Vinicius S Nunes; Jeziel D Damasceno; Raimundo Freire; Luiz R O Tosi
Journal:  Mol Biochem Parasitol       Date:  2011-02-01       Impact factor: 1.759

9.  Genetic analysis of spermidine synthase from Leishmania donovani.

Authors:  S C Roberts; Y Jiang; A Jardim; N S Carter; O Heby; B Ullman
Journal:  Mol Biochem Parasitol       Date:  2001-07       Impact factor: 1.759

10.  Tetracycline regulated gene expression in Leishmania donovani.

Authors:  S Yan; P J Myler; K Stuart
Journal:  Mol Biochem Parasitol       Date:  2001-01-15       Impact factor: 1.759

View more
  5 in total

1.  Leishmania guyanensis M4147 as a new LRV1-bearing model parasite: Phosphatidate phosphatase 2-like protein controls cell cycle progression and intracellular lipid content.

Authors:  Alexandra Zakharova; Amanda T S Albanaz; Fred R Opperdoes; Ingrid Škodová-Sveráková; Diana Zagirova; Andreu Saura; Lˇubomíra Chmelová; Evgeny S Gerasimov; Tereza Leštinová; Tomáš Bečvář; Jovana Sádlová; Petr Volf; Julius Lukeš; Anton Horváth; Anzhelika Butenko; Vyacheslav Yurchenko
Journal:  PLoS Negl Trop Dis       Date:  2022-06-24

Review 2.  Genetically modified organisms and visceral leishmaniasis.

Authors:  Rudra Chhajer; Nahid Ali
Journal:  Front Immunol       Date:  2014-05-14       Impact factor: 7.561

3.  Deletion of Glutamine Synthetase Gene Disrupts the Survivability and Infectivity of Leishmania donovani.

Authors:  Vinay Kumar; Sanhita Ghosh; Kamalika Roy; Chiranjib Pal; Sushma Singh
Journal:  Front Cell Infect Microbiol       Date:  2021-02-26       Impact factor: 5.293

4.  Depletion of UDP-Glucose and UDP-Galactose Using a Degron System Leads to Growth Cessation of Leishmania major.

Authors:  Sebastian Damerow; Carolin Hoppe; Giulia Bandini; Patricia Zarnovican; Falk F R Buettner; Falk R Buettner; Carsten G K Lüder; Michael A J Ferguson; Françoise H Routier
Journal:  PLoS Negl Trop Dis       Date:  2015-11-03

5.  Growth arrested live-attenuated Leishmania infantum KHARON1 null mutants display cytokinesis defect and protective immunity in mice.

Authors:  Ana Maria Murta Santi; Juliane Sousa Lanza; Luiza Guimarães Tunes; Jacqueline Araújo Fiuza; Gaétan Roy; Alessandra da Silva Orfanó; Andréa Teixeira de Carvalho; Frédéric Frézard; André Luís Branco de Barros; Silvane Maria Fonseca Murta; Rubens Lima do Monte-Neto
Journal:  Sci Rep       Date:  2018-08-02       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.